Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5641 to 5655 of 7707 results

  1. Active surveillance compared with surgery: For people with stage 1 differentiated thyroid cancer, what is the clinical and cost effectiveness of active surveillance compared with surgery?

    Recommendation ID NG230/03 Question Active surveillance compared with surgery: For people with stage 1 differentiated thyroid cancer, what

    Research recommendation
    Published
    6 January 2023

  2. FRAX and QFracture in adults receiving bone protective therapy:- What is the utility of FRAX and QFracture in adults receiving bone protective therapy?

    Recommendation ID CG146/2 Question FRAX and QFracture in adults receiving bone protective therapy:- What is the utility of FRAX and QFracture

    Research recommendation
    Published
    9 June 2015

  3. FRAX and QFracture in adults with secondary causes of osteoporosis:- What is the utility of FRAX and QFracture in detecting risk of fragility fracture in adults with secondary causes of osteoporosis?

    Recommendation ID CG146/3 Question FRAX and QFracture in adults with secondary causes of osteoporosis:- What is the utility of FRAX and

    Research recommendation
    Published
    9 June 2015

  4. Undisplaced intracapsular hip fractures: For people with undisplaced (or non-displaced) intracapsular hip fracture, what features should be used to characterise the injury and what are the optimal clinical and cost-effective management strategies?

    Recommendation ID CG124/03 Question Undisplaced intracapsular hip fractures: For people with undisplaced (or non-displaced) intracapsular

    Research recommendation
    Published
    3 February 2023

  5. What are the benefits of planned, regular community-based reviews compared with as-required review of non-cancer patients approaching the end of their life?

    Recommendation ID NG142/3 Question What are the benefits of planned, regular community-based reviews compared with as-required review of

    Research recommendation
    Published
    18 November 2019

  6. For people with unfavourable aneurysm morphology needing an endovascular aortic aneurysm repair (EVAR) as a primary procedure, or for people with an existing EVAR who need a secondary procedure, evidence on the safety of using endoanchoring systems is adequate. Evidence on efficacy is limited in quantity and quality. Therefore, for these people, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    Recommendation ID IPG725/01 Question For people with unfavourable aneurysm morphology needing an endovascular aortic aneurysm repair (EVAR)

    Research recommendation
    Published
    1 June 2022

  7. How can the design and reporting of the outcomes used in intervention studies be improved, so researchers can identify 'active ingredients'? Which validated tools are effective at consistently measuring success, especially in relation to health and wellbeing, performance, productivity and in economic terms?

    Recommendation ID NG13/4 Question How can the design and reporting of the outcomes used in intervention studies be improved, so researchers

    Research recommendation
    Published
    5 October 2015

  8. How can the effectiveness and cost effectiveness of condom schemes in the UK be improved for people at most risk of STIs? How can we ensure the effectiveness and cost effectiveness of the C-Card and other UK-based condom schemes for preventing sexually transmitted infections (STIs) and unintended pregnancies among groups at high risk? What are the essential components of an effective scheme?

    Recommendation ID NG68/2 Question How can the effectiveness and cost effectiveness of condom schemes in the UK be improved for people at

    Research recommendation
    Published
    12 October 2018

  9. How can the effectiveness of workplace health policies and programmes be measured?

    Recommendation ID NG13/3 Question How can the effectiveness of workplace health policies and programmes be measured? Any explanatory

    Research recommendation
    Published
    5 October 2015

  10. How can the factors that pose a risk to, or protect, the social and emotional wellbeing of children aged under 5 years be identified and assessed to determine how children can benefit from different interventions?

    Recommendation ID PH40/2 Question How can the factors that pose a risk to, or protect, the social and emotional wellbeing of children aged

    Research recommendation
    Published
    9 June 2015

  11. How can the implementation of the recommendations made in this guideline be evaluated?

    Recommendation ID NG13/1 Question How can the implementation of the recommendations made in this guideline be evaluated? Any explanatory

    Research recommendation
    Published
    5 October 2015

  12. How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased risk will begin and complete hepatitis C treatment?

    Recommendation ID PH43/2 Question How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific

    Research recommendation
    Published
    9 June 2015

  13. Independent advocacy: How can the views of babies, children and young people be best represented by independent advocates?

    Recommendation ID NG204/2 Question Independent advocacy: How can the views of babies, children and young people be best represented by

    Research recommendation
    Published
    30 September 2021

  14. Delirium in long-term care: How common is delirium and what are its adverse outcomes in people in long-term care?

    Recommendation ID CG103/05 Question Delirium in long-term care: How common is delirium and what are its adverse outcomes in people in long-term

    Research recommendation
    Published
    3 February 2023

  15. How cost effective are alternative testing sites, such as community pharmacist programmes, for increasing the number of people who are tested and treated for hepatitis B and C?

    Recommendation ID PH43/5 Question How cost effective are alternative testing sites, such as community pharmacist programmes, for increasing

    Research recommendation
    Published
    9 June 2015